ACCESS BIO Trademark

Trademark Overview

On Tuesday, September 7, 1999, a trademark application was filed for ACCESS BIO with the United States Patent and Trademark Office. The USPTO has given the ACCESS BIO trademark a serial number of 75793826. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 25, 2000. This trademark is owned by Access Bio,.L.C.. The ACCESS BIO trademark is filed in the Advertising, Business and Retail Services category with the following description:

Consulting services in science-based regulatory strategies and development services to facilitate biomedical research, emerging technologies and biotechnology development
access bio

General Information

Serial Number75793826
Word MarkACCESS BIO
Filing DateTuesday, September 7, 1999
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, September 25, 2000
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesConsulting services in science-based regulatory strategies and development services to facilitate biomedical research, emerging technologies and biotechnology development

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, November 30, 1999
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAccess Bio,.L.C.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLovettsviller, VA 20180

Trademark Events

Event DateEvent Description
Monday, September 25, 2000ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, February 23, 2000NON-FINAL ACTION MAILED
Friday, February 4, 2000ASSIGNED TO EXAMINER

Related Keywords

access services development research emerging technologies biotechnology biomedical facilitate based regulatory